- Home
- AQST vs GMRS Comparison
AQST vs GMRS Comparison
Compare AQST & GMRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AQST | GMRS |
|---|---|---|
| Founded | 2004 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 529.4M | 551.0M |
| IPO Year | 2007 | 2026 |
Fundamental Metrics
Financial Performance| Metric | AQST | GMRS |
|---|---|---|
| Price | $4.63 | $10.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 8 |
| Target Price | $9.33 | ★ $18.63 |
| AVG Volume (30 Days) | ★ 2.1M | 913.5K |
| Earning Date | 11-04-2026 | 08-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $67,430,000.00 | N/A |
| Revenue This Year | $12.09 | $5.13 |
| Revenue Next Year | $35.73 | $5.57 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.77 | N/A |
| 52 Week Low | $2.94 | $9.00 |
| 52 Week High | $7.55 | $15.98 |
Technical Indicators
Market Signals| Indicator | AQST | GMRS |
|---|---|---|
| Relative Strength Index (RSI) | 47.09 | 36.63 |
| Support Level | $4.51 | N/A |
| Resistance Level | $4.69 | $14.44 |
| Average True Range (ATR) | 0.22 | 0.64 |
| MACD | -0.04 | -0.11 |
| Stochastic Oscillator | 28.36 | 26.97 |
Price Performance
Historical ComparisonAbout AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About GMRS GMR Solutions Inc. Class A Common Stock
GMR Solutions Inc is a holding company, along with its various subsidiaries, that delivers compassionate, quality medical care, meeting a patient's unplanned and planned care needs. The group provides emergent, non-emergent, disaster response, and event medical services across the healthcare ecosystem, serving local communities, health systems, payors, public health, and local, state, and federal agencies within the United States.